2005Pharmaceutical Journal of Chinese People's Liberation ArmyRequires access

Study on Pharmacokinetics and Bioequivalence of Azithromycin for Suspension in Healthy Volunteers

Xiao Li

Open publisher page 0 citations

Abstract

Aim To study the pharmacokinetics and bioequivalence of Azithromycin for Suspension in healthy volunteers.Methods The concentration of Azithromycin for Suspension of 20 male subjects were determined after oral administration 500mg tested and referenced by liquid chromatographic-mass-mass spectrometric and caculated main pharmacokinetics parameters,analyses bioequivalence of two formulations by two one t test and(1-2α)90%.Results The main pharmacokinetics of tested and referenced were follows:T_(max) were(2.30±0.55)h and(2.25±0.53)h;C_(max) were(478.4±133.9)ng·ml~(-1) and(562.6±132.9)ng·ml~(-1),T_(1/2) were(30.1±8.3)h and(32.4±9.4)h;AUC_(0-t) were(4 263±1 341)ng·h·ml~(-1) and(4 511±918)ng·h·ml~(-1),respectively.The relative bioavailability of the test formulation was(95.2±21.5)%.Conclusion The two kinds of Azithromycin were bioequivalent in healthy volunteers.

About this research paper

What this paper is about

Aim To study the pharmacokinetics and bioequivalence of Azithromycin for Suspension in healthy volunteers.Methods The concentration of Azithromycin for Suspension of 20 male subjects were determined after oral administration 500mg tested and referenced by liquid chromatographic-mass-mass spectrometric and caculated main pharmacokinetics parameters,analyses bioequivalence of two formulations by two one t test and(1-2α)90%.Results The main pharmacokinetics of tested and referenced were follows:T_(max) were(2.30±0.55)h and(2.25±0.53)h;C_(max) were(478.4±133.9)ng·ml~(-1) and(562.6±132.9)ng·ml~(-1),T_(1/2) were(30.1±8.3)h and(32.4±9.4)h;AUC_(0-t) were(4 263±1 341)ng·h·ml~(-1) and(4 511±918)ng·h·ml~(-1),respectively.The relative bioavailability of the test formulation was(95.2±21.5)%.Conclusion The two kinds of Azithromycin were bioequivalent in healthy volunteers.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aim To study the pharmacokinetics and bioequivalence of Azithromycin for Suspension in healthy volunteers.Methods The concentration of Azithromycin for Suspension of 20 male subjects were determined after oral administration 500mg tested and referenced by liquid chromatographic-mass-mass spectrometric and caculated main pharmacokinetics parameters,analyses bioequivalence of two formulations by two one t test and(1-2α)90%.Results The main pharmacokinetics of tested and referenced were follows:T_(max) were(2.30±0.55)h and(2.25±0.53)h;C_(max) were(478.4±133.9)ng·ml~(-1) and(562.6±132.9)ng·ml~(-1),T_(1/2) were(30.1±8.3)h and(32.4±9.4)h;AUC_(0-t) were(4 263±1 341)ng·h·ml~(-1) and(4 511±918)ng·h·ml~(-1),respectively.The relative bioavailability of the test formulation was(95.2±21.5)%.Conclusion The two kinds of Azithromycin were bioequivalent in healthy volunteers.

Key concepts: Bioequivalence, Azithromycin, Pharmacokinetics, Bioavailability, Pharmacology, Chromatography, Medicine, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on Pharmacokinetics and Bioequivalence of Azithromycin for Suspension in Healthy Volunteers — Research Paper | ScholarLens